The novelty is based on a new mechanism by which the amyloid peptide, the main pathogen in Alzheimer’s disease, provokes neuronal death. The Basque researchers have discovered that this peptide activates some receptors that lead cells to subsequent and overexcitation loss of life; when such receptors are blocked with particular drugs, neurons are guarded from the peptide-related lethal results. This finding is specially relevant for the advancement of new treatments slowing Alzheimer’s progression. The extensive research work was supervised by Dr. Carlos Matute, Director of Neurotek analysis centre and Mind of the Neurobiology Laboratory of the Neurosciences Section at the University of the Basque Nation . The research group led by Dr.‘With the levels of heart disease on the rise in the U.S., the medical community must remain vigilant inside our efforts to supply patients with tools and information that can help enhance the quality of their lives,’ says Jack Stroh, an Interventional Cardiologist at Robert Solid wood Johnson University St and Medical center. Peter's University Hospital in NJ, and advisor to CathMaps+. Related StoriesACC's public reporting plan provides information about hospitals' performanceNew UCLA study looks at primary care medical house in reducing childrens' do it again visits to hospitalsAnxiety associated with poor asthma outcomesApproximately 715, 000 People in america have a heart attack each year, according to the Centers for Disease Control.